116 related articles for article (PubMed ID: 15539136)
21. [Idiosyncratic drug toxicity].
Ikeda T
Chudoku Kenkyu; 2012 Mar; 25(1):11-9. PubMed ID: 22568339
[No Abstract] [Full Text] [Related]
22. Application of systems pharmacology to explore mechanisms of hepatotoxicity.
Shon J; Abernethy DR
Clin Pharmacol Ther; 2014 Nov; 96(5):536-7. PubMed ID: 25336266
[TBL] [Abstract][Full Text] [Related]
23. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
Menon KVN ; Angulo P; Lindor KD
Am J Gastroenterol; 2001 May; 96(5):1631-4. PubMed ID: 11374713
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced hepatotoxicity: 2005.
Maddrey WC
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S83-9. PubMed ID: 15758665
[TBL] [Abstract][Full Text] [Related]
25. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.
Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM
Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975
[TBL] [Abstract][Full Text] [Related]
26. Hepatic dysfunction associated with troglitazone.
Watkins PB; Whitcomb RW
N Engl J Med; 1998 Mar; 338(13):916-7. PubMed ID: 9518284
[No Abstract] [Full Text] [Related]
27. [Evaluation of thiazolidinedione derivative drugs for safety].
Kobayashi M; Iwata M
Nihon Rinsho; 2001 Nov; 59(11):2228-32. PubMed ID: 11712412
[TBL] [Abstract][Full Text] [Related]
28. Thiazolidinedione hepatotoxicity: a class effect?
Tolman KG
Int J Clin Pract Suppl; 2000 Oct; (113):29-34. PubMed ID: 11965828
[TBL] [Abstract][Full Text] [Related]
29. In vitro investigation of the glutathione transferase M1 and T1 null genotypes as risk factors for troglitazone-induced liver injury.
Usui T; Hashizume T; Katsumata T; Yokoi T; Komuro S
Drug Metab Dispos; 2011 Jul; 39(7):1303-10. PubMed ID: 21511944
[TBL] [Abstract][Full Text] [Related]
30. [Clinical effect and side effect of troglitazone].
Toyota T; Ueno Y
Nihon Rinsho; 2000 Feb; 58(2):376-82. PubMed ID: 10707561
[TBL] [Abstract][Full Text] [Related]
31. The use of hepatotoxic signals to predict the safety of peroxisome proliferator-activated receptor agonists.
Hastings KL
Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):489-92. PubMed ID: 16859399
[No Abstract] [Full Text] [Related]
32. A novel antidiabetic drug, troglitazone--reason for hope and concern.
Imura H
N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
[No Abstract] [Full Text] [Related]
33. Vismodegib-associated hepatotoxicity: a potential side effect detected in postmarketing surveillance.
Ventarola DJ; Silverstein DI
J Am Acad Dermatol; 2014 Aug; 71(2):397-8. PubMed ID: 25037792
[No Abstract] [Full Text] [Related]
34. SNP communications: coalition of toxicology and drug metabolism and pharmacokinetics.
Ikeda T
Drug Metab Pharmacokinet; 2007 Apr; 22(2):65-6. PubMed ID: 17495412
[No Abstract] [Full Text] [Related]
35. Drug-induced hepatotoxicity.
Lee WM
N Engl J Med; 2003 Jul; 349(5):474-85. PubMed ID: 12890847
[No Abstract] [Full Text] [Related]
36. From the Food and Drug Administration.
Nightingale SL
JAMA; 1997 Dec; 278(21):1728. PubMed ID: 9388135
[No Abstract] [Full Text] [Related]
37. [Meta-analysis shows: insulin sensitizer is safe for the liver].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
[No Abstract] [Full Text] [Related]
38. Second-generation thiazolidinediones and hepatotoxicity.
Marcy TR; Britton ML; Blevins SM
Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
[TBL] [Abstract][Full Text] [Related]
39. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
Kohlroser J; Mathai J; Reichheld J; Banner BF; Bonkovsky HL
Am J Gastroenterol; 2000 Jan; 95(1):272-6. PubMed ID: 10638596
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
Ong MM; Latchoumycandane C; Boelsterli UA
Toxicol Sci; 2007 May; 97(1):205-13. PubMed ID: 17150972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
